Exploring the feasibility of using the DBS technique for metabolite radioprofiling

Bioanalysis

Volumn 2, Issue 8, 2010, Pages 1365-1371

  Wang, Lijuan ^a   Zeng, Zhaopie ^a   Emmons, Gary ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; DRUG; DRUG METABOLITE; SA 1; UNCLASSIFIED DRUG; RADIOISOTOPE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOG; DRIED BLOOD SPOT SAMPLING; DRUG DISTRIBUTION; DRUG METABOLISM; FEASIBILITY STUDY; INTERMETHOD COMPARISON; ISOTOPE LABELING; MALE; METABOLITE RADIOPROFILING; NONHUMAN; PLASMA; RADIOACTIVITY; RADIOCHROMATOGRAPHY; REPRODUCIBILITY; SINGLE DRUG DOSE; TEST STRIP; ANIMAL; BLOOD; BLOOD ANALYSIS; CHEMISTRY; DESICCATION; HUMAN; METABOLISM; METHODOLOGY; PHARMACOKINETICS; TOXICOLOGY;

ANIMALS; BLOOD CHEMICAL ANALYSIS; BLOOD SPECIMEN COLLECTION; DESICCATION; FEASIBILITY STUDIES; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PLASMA; RADIOISOTOPES; REPRODUCIBILITY OF RESULTS; TOXICOLOGY;

EID: 79951751268     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.10.100     Document Type: Article

References (21)

1. Barfeld M, Spooner N, Lad R, Parry S, Fowles S. Application of dried blood spots combined with HPLC-MS/MS for the quantifcation of acetaminophen in toxicokinetic studies. J. Chromatogr. B. 870, 32-37 (2008).
2. Liang X, Li Y, Barfeld M, Ji QC. Study of dried blood spots techniques for the determination of dextromethorphan and its metabolite dextrorphan in human whole blood by LC-MS/MS, J. Chromatogr. B. 877, 799-806 (2009).
3. Spooner N, Lad R, Barfeld M. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method. Anal. Chem. 81, 1557-1563 (2009).
4. Abu-Rabie P, Spooner N. Direct quantitative bioanalysis of drugs in dried blood spot samples using a thin-layer chromatography mass spectrometer interfaces. Anal. Chem. 81, 10275-10284 (2009).
5. Déglon J, Thomas A, Cataldo A, Mangin P, Staub C Online desorption of dried blood spot: a novel approach for the direct LC-MS analysis of μ-whole blood samples. J. Pharm. Biomed. Anal. 49, 1034-1039 (2009).
6. Thomas A, Déglon J, Steimer T, Mangin P, Daali Y, Staub C Online desorption of dried blood spots coupled to hydrophilic interaction/reversed- phase LC-MS/MS system for the simultaneous analysis of drugs and their polar metabolites. J. Sep. Sci. 33, 1-7 (2009).
7. La Marca G, Malvagia S, Filippi L, Luceri F, Moneti G, Guerrini R. A new rapid micromethod for the assay of phenobarbital from dried blood spots by LC-tandem mass spectrometry. Epilepsia 50, 2658-2662 (2009).
8. Van Berkel GJ, Kertesz V. Application of a liquid extraction based sealing surface sampling probe for mass spectrometric analysis of dried blood spots and mouse whole-body thin tissue sections. Anal. Chem. 81, 9146-9152 (2009).
9. Heine R, Rosing H, Van Gorp ECM, Mulder JW, Beijnen JH, Huitema ADR. Quantifcation of etravirine (TMC125) in plasma, dried blood spots and peripheral blood mononuclear cell lysate by liquid chromatography tandem mass spectrometry. J. Pharm. Biomed. Anal. 49, 393-400 (2009).
10. Li W, Tse FLS. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed. Chromatog. 24, 49-65 (2010).
11. Wiseman JM, Evans CA, Bowen CL, Kennedy JH. Direct analysis of dried blood spots utilizing desorption electrospray ionization (DESI) mass spectrometry Analyst 135, 720-725 (2010).
12. Beaudette P, Bateman KP. Discovery stage pharmacokinetics using dried blood spots. J. Chromatogr. B 809, 151-158 (2004).
13. Mauriala T, Chauret N, Oballa R. Nicoll-Griffth DA, Bateman KP. A strategy for identifcation of drug metabolites from dried blood spots using triple-quadrupole/linear ion trap hybrid mass spectrometry Rapid Commun. Mass Spectrom. 19, 1984-1992 (2005). (Pubitemid 41026421)
14. Edelbroek PM, van der Heijden J, Stolk LML. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls. Ther. Drug Monit. 31, 327-336 (2009).
15. Rowland M, Emmons GT. Use of dried blood spots in drug development: pharmacokinetic considerations. AAPS J. April 10 (2010).
16. Riad LE, Chan KK, Sawchuk RJ. Determination of the relative formation and elimination clearance of two major carbamazepine metabolites in humans: a comparison between traditional and pooled sample analysis. Pharm. Res. 8, 541-543 (1991).
17. Louton T, Kuhnz W, Dibbelt L, Knuppen R. Weighted serum pools in comparison to the trapezoidal rule for estimating AUCs for ethinyl estradiol: the relationship of the variance of the determination to the interindividual variance. Eur. J. Clin. Pharmacol. 46, 77-81 (1994). (Pubitemid 24067593)
18. Tiller PR, Yu S, Bateman KP et al. Fractional mass fltering as a means to assess circulating metabolites in early human clinical studies. Rapid. Commun. Mass Spectrom. 22, 3510-351 6 (2008).
19. Nedderman ANR. Metabolites in safety testing: metabolite identifcation strategies in discovery and development. Biopharm. Drug Dispos. 30, 153-162 (2009).
20. Zhu M, Zhang D, Zhang H, Shyu WC. Integrated strategies for assessment of metabolite exposure in humans during drug development: analytical challenges and clinical development considerations. Biopharm. Drug Dispos. 30, 163-184 (2009).
21. Penner N, Klunk LJ, Prakash C Human radiolabeled mass balance studies: objectives, utilities and limitations. Biopharm. Drug Dispos. 30, 185-203 (2009).